![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
New Drugs to Prevent Recurrence of Renal Stone Disease
Many patients who are stone formers have recurrent stone formation, for which detailed clinical and biochemical work-up is necessary. Even if conventional treatments with thiazides, orthophosphate, or magnesiu...
-
Chapter
Intestinal Absorption of Oxalate and Calcium
The majority of renal stones contain calcium oxalate (1, 2). In patients with idiopathic calcium stone disease, an increased excretion of both calcium and oxalate is reported (3, 4). After jejuno-ileal bypass ...
-
Chapter and Conference Paper
Clinical characteristics of renal stone disease in relation to urinary oxalate excretion
The formation of calcium-containing renal stones is regarded as a multifactorial process involving high urinary concentrations of calcium and oxalate in combination with reduced excretion of inhibitory factors...
-
Chapter and Conference Paper
The mechanism of glycosaminoglycan inhibition of calcium oxalate crystal growth
Urinary inhibition of crystal growth and aggregation is an important determinant for stone formation in the urinary tract along with supersaturation of the urine (1). Naturally occurring inhibitors such as pyr...